Endo and Penwest Announce Settlement of Opana(R) ER . ( CHADDS .Endo Pharmaceuticals is a specialty pharmaceutical company engaged in the research, development, sale and marketing of branded and generic prescription pharmaceuticals used primarily to treat and manage pain. .
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. .TITUSVILLE, NJ, February 06, 2009 /PRNewswire/ — Johnson & Johnson Pharmaceutical Research & Development, LLC (J&JPRD) today announced that.
Scientists at deCODE genetics (Nasdaq: DCGN) present the discovery of two single letter variations in the sequence of the human genome (SNPs) conferring substantial increased risk of thyroid cancer. The two SNPs, located on chromosomes 9q22 and 14q13, are the first common variants replicated in multiple populations ever associated with increased risk of the disease. pharmaceutical r&d
ROXRO announced that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for its lead investigational prescription drug candidate, ROX-888, for the management of acute moderate to severe pain. pharmaceutical r&d
